Experience

California NanoSystems Institute at UCLA

• United States
• Higher Education
• 1 - 100 Employee

• Graduate Student Researcher

  • Jul 2023 - Present

  ∙ Currently developing standard operating procedures to automate bacterial plasmid purification (mini-preps) in the Living Biofoundry, a high-throughput automated platform for synthetic biology. ∙ Gained experience in using the ThermoFisher Laboratory Automation System (LAS) and Tecan Fluent automated liquid handler. ∙ Currently developing standard operating procedures to automate bacterial plasmid purification (mini-preps) in the Living Biofoundry, a high-throughput automated platform for synthetic biology. ∙ Gained experience in using the ThermoFisher Laboratory Automation System (LAS) and Tecan Fluent automated liquid handler.



UCLA

• United States
• Higher Education
• 700 & Above Employee

• Masters Student

  • Apr 2023 - Present

  ∙ Designed and implemented a fully independent study of a novel Pseudomonas aeruginosa receptor-binding protein (“PAB92”), selected from an M13 phage display library, in preparation for master’s thesis. ∙ Successfully constructed a recombinant plasmid encoding PAB92 and performed heterologous protein overexpression in Escherichia coli and purification via IMAC.

• Teaching Assistant

  • Apr 2023 - Jun 2023

  ∙ Taught laboratory sections 8+ hours per week for upper-division undergraduate CBE course 104D Molecular Biotechnology Lecture/Laboratory: From Gene to Product, which covers DNA cloning, cell culturing, fermentation, FPLC, and enzymatic assays for the expression and characterization of recombinant proteins.

• Undergraduate Research Assistant

  • Jan 2021 - Mar 2023

  ∙ Screened for novel receptor-binding proteins targeting clinically relevant bacterial strains, such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Salmonella enterica, from an M13 phage display library of random peptides. ∙ Developed an assay to quantify M13 bacteriophage binding to target bacterial strains, exploring various experimental techniques such as flow cytometry, qPCR, and co-precipitation with magnetic beads. ∙ Analyzed the physicochemical, antibacterial, and toxicity properties of silver nanoparticle-M13 conjugates as a novel therapeutic for multi-drug resistant bacterial infections, gaining experience in TEM, DLS, bacterial growth curve assays, and cytotoxicity assays. Show less



California NanoSystems Institute at UCLA

• United States
• Higher Education
• 1 - 100 Employee

• Work-study Lab Assistant

  • Nov 2021 - Mar 2023

  ∙ Prepared experiment kits for the CNSI Educational Outreach Program, which aims to encourage K-12 students to pursue studies in STEM fields by providing hands-on nanoscience experiments for local classrooms and on-campus summer programs. ∙ Leveraged academic and research background to revise and troubleshoot protocols for experiments covering a wide range of topics like biosensors, biotoxicity, and superhydrophobic surfaces. ∙ Prepared experiment kits for the CNSI Educational Outreach Program, which aims to encourage K-12 students to pursue studies in STEM fields by providing hands-on nanoscience experiments for local classrooms and on-campus summer programs. ∙ Leveraged academic and research background to revise and troubleshoot protocols for experiments covering a wide range of topics like biosensors, biotoxicity, and superhydrophobic surfaces.



Sanofi

• France
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Medical Affairs Intern

  • Mar 2021 - Sep 2021

  ∙ Presented on literature supporting Adacel® Tdap (tetanus, diphtheria, and pertussis) vaccination in pregnant women for passive neonatal immunity, contributing to regulatory affairs’ decision to push for Korean FDA approval of an expanded indication. ∙ Led scientific education on key evidence supporting the importance of influenza vaccination under the COVID-19 context to cross-functional teams, including marketing, regulatory affairs, and 40+ sales associates. ∙ Presented on literature supporting Adacel® Tdap (tetanus, diphtheria, and pertussis) vaccination in pregnant women for passive neonatal immunity, contributing to regulatory affairs’ decision to push for Korean FDA approval of an expanded indication. ∙ Led scientific education on key evidence supporting the importance of influenza vaccination under the COVID-19 context to cross-functional teams, including marketing, regulatory affairs, and 40+ sales associates.